INTEGRA LIFESCIENCES HOLDINGS CORP Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets of 3.70% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedBenefitPlanAssumptionsUsedCalculatingNetPeriodicBenefitCostExpectedLongTermReturnOnAssets · last filed 2026-02-26
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2025 was 3.70%, a 1.37% increase from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2024 was 3.65%, a 0.54% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2023 was 3.67%, a 1.66% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP defined benefit plan, assumptions used calculating net periodic benefit cost, expected long-term rate of return on plan assets for fiscal 2022 was 3.61%, a 0.56% increase from fiscal 2021.
| Period end | Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-term Rate of Return on Plan Assets 12 month |
|---|---|
| 2025-12-31 | 3.70% 10-K · filed 2026-02-26 |
| 2024-12-31 | 3.65% 10-K · filed 2026-02-26 |
| 2023-12-31 | 3.67% 10-K · filed 2026-02-26 |
| 2022-12-31 | 3.61% 10-K · filed 2024-02-28 |
| 2021-12-31 | 3.59% 10-K · filed 2023-02-22 |
| 2020-12-31 | 2.04% 10-K · filed 2022-02-24 |
| 2019-12-31 | 3.33% 10-K · filed 2021-02-23 |
| 2018-12-31 | 3.40% 10-K · filed 2020-02-21 |
| 2017-12-31 | 3.08% 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |